Shmuel Klang

764 total citations
12 papers, 546 citations indexed

About

Shmuel Klang is a scholar working on Pharmaceutical Science, Oncology and Organic Chemistry. According to data from OpenAlex, Shmuel Klang has authored 12 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmaceutical Science, 3 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Shmuel Klang's work include Advanced Drug Delivery Systems (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and Surfactants and Colloidal Systems (2 papers). Shmuel Klang is often cited by papers focused on Advanced Drug Delivery Systems (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and Surfactants and Colloidal Systems (2 papers). Shmuel Klang collaborates with scholars based in Israel, United States and France. Shmuel Klang's co-authors include Ariel Hammerman, Simon Benita, Shmuel Giveon, Ernesto Kahan, Nicky Liebermann, John Hornberger, Noa Efrat, Julie Doberne, Amnon Hoffman and Joseph Frucht‐Pery and has published in prestigious journals such as The American Journal of Gastroenterology, International Journal of Pharmaceutics and Breast Cancer Research and Treatment.

In The Last Decade

Shmuel Klang

12 papers receiving 519 citations

Peers

Shmuel Klang

PS

ONCOL

CR

MB

PRM

Lijing Zhang China

Duc P. United States

Binbin Song China

Jianjun Zhang China

Sarah Rogers United States

Xuechao Li China

Rajendran C. Gopalan United Kingdom

Angela Wehr United States

André Farkouh Austria

Jyoti Kaushal India

Lijing Zhang China

Shmuel Klang

30 ×0.2

PS

57 ×0.4

ONCOL

98 ×0.9

CR

166 ×2.0

MB

97 ×1.3

PRM

Citations per year, relative to Shmuel Klang Shmuel Klang (= 1×) peers Lijing Zhang

Countries citing papers authored by Shmuel Klang

Since Specialization

Citations

This map shows the geographic impact of Shmuel Klang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shmuel Klang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shmuel Klang more than expected).

Fields of papers citing papers by Shmuel Klang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shmuel Klang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shmuel Klang. The network helps show where Shmuel Klang may publish in the future.

Co-authorship network of co-authors of Shmuel Klang

This figure shows the co-authorship network connecting the top 25 collaborators of Shmuel Klang. A scholar is included among the top collaborators of Shmuel Klang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shmuel Klang. Shmuel Klang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Klang, Shmuel, et al.. (2015). Community pharmacists’ support improves antidepressant adherence in the community. International Clinical Psychopharmacology. 30(6). 316–319. 14 indexed citations

2.

Stemmer, Salomon M., Shmuel Klang, Noa Ben-Baruch, et al.. (2013). The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients. Breast Cancer Research and Treatment. 140(1). 83–92. 34 indexed citations

3.

Liebermann, Nicky, et al.. (2011). [Identification of K-RAS mutations in colorectal cancer patients in Israel].. PubMed. 150(5). 447–50, 491. 6 indexed citations

4.

Klang, Shmuel, Ariel Hammerman, Nicky Liebermann, et al.. (2010). Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization. Value in Health. 13(4). 381–387. 94 indexed citations

5.

Levi, Zohar, Paul Rozen, Rachel Hazazi, et al.. (2009). Sensitivity, but Not Specificity, of a Quantitative Immunochemical Fecal Occult Blood Test for Neoplasia Is Slightly Increased by the Use of Low-Dose Aspirin, NSAIDS, and Anticoagulants. The American Journal of Gastroenterology. 104(4). 933–938. 63 indexed citations

6.

Hammerman, Ariel, Jacob Dreiher, Shmuel Klang, et al.. (2008). Antipsychotics and Diabetes: An Age-Related Association. Annals of Pharmacotherapy. 42(9). 1316–1322. 51 indexed citations

7.

Giveon, Shmuel, et al.. (2003). Are people who use “natural drugs” aware of their potentially harmful side effects and reporting to family physician?. Patient Education and Counseling. 53(1). 5–11. 87 indexed citations

8.

Klang, Shmuel, et al.. (2000). Influence of Emulsion Droplet Surface Charge on Indomethacin Ocular Tissue Distribution. Pharmaceutical Development and Technology. 5(4). 521–532. 63 indexed citations

9.

Klang, Shmuel, et al.. (1996). The stability of piroxicam incorporated in a positively-charged submicron emulsion for ocular administration. International Journal of Pharmaceutics. 132(1-2). 33–44. 26 indexed citations

10.

Klang, Shmuel, et al.. (1994). Physicochemical Characterization and Acute Toxicity Evaluation of a Positively-charged Submicron Emulsion Vehicle. Journal of Pharmacy and Pharmacology. 46(12). 986–993. 58 indexed citations

11.

Klang, Shmuel, et al.. (1994). The design and characterization of a positively charged submicron emulsion containing a sunscreen agent. International Journal of Pharmaceutics. 108(1). 57–68. 14 indexed citations

12.

Klang, Shmuel, et al.. (1993). Positively charged submicron emulsions — a new type of colloidal drug carrier. International Journal of Pharmaceutics. 96(1-3). R1–R6. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact